Progesterone is a steroid hormone involved in the female menstrual cycle, pregnancy, and the embryonic development of humans and other species. Progesterone belongs to a class of hormones called progestogens. This steroid hormone is produced in the ovaries, the adrenal glands, and in the placenta during pregnancy.
This report aims to provide a comprehensive presentation of the global market for Allogeneic Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allogeneic Stem Cells. This report contains market size and forecasts of Allogeneic Stem Cells in global, including the following market information:
Global Allogeneic Stem Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Allogeneic Stem Cells market was valued at US$ 779.2 million in 2022 and is projected to reach US$ 1513.9 million by 2029, at a CAGR of 10.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the past, in the field of upstream production of steroid drugs, due to the late start of domestic biotechnology research, it was relatively backward compared to foreign manufacturers. However, after decades of development, China's production technology has been continuously improved, and its cost advantage is more obvious. Now, domestic steroid raw material manufacturers have gradually become the mainstream suppliers of steroid drug products, and foreign steroid drug giants have used steroid drugs upstream. Procurement of product starting materials and intermediates shifted to Asia-Pacific region, mainly China, and global steroid drug production center gradually moved to Asia-Pacific region.
The Progesterone is a high concentration industry. The annual production is about few hundred Tonnes. Currently, the global top three manufacturers are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical. Their revenue market share is about 52%. In short future, the competition pattern will not change.
We surveyed the Allogeneic Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allogeneic Stem Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cells Market Segment Percentages, by Type, 2022 (%)
Progesterone Oral
Progesterone Injection
Progesterone Suspended/Gel
Global Allogeneic Stem Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Allogeneic Stem Cells Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Pharmacies & Drug Stores
Global Allogeneic Stem Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Allogeneic Stem Cells Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allogeneic Stem Cells revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Allogeneic Stem Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Teva Generics
Zhejiang Medicine
Zhejiang Aisheng Pharmaceutical
Besins Healthcare
Virtus Pharmaceuticals
BionPharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Allogeneic Stem Cells, market overview.
Chapter 2: Global Allogeneic Stem Cells market size in revenue.
Chapter 3: Detailed analysis of Allogeneic Stem Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Allogeneic Stem Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Allogeneic Stem Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Allogeneic Stem Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Allogeneic Stem Cells Overall Market Size
2.1 Global Allogeneic Stem Cells Market Size: 2022 VS 2029
2.2 Global Allogeneic Stem Cells Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Allogeneic Stem Cells Players in Global Market
3.2 Top Global Allogeneic Stem Cells Companies Ranked by Revenue
3.3 Global Allogeneic Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Allogeneic Stem Cells Companies in Global Market, by Revenue in 2022
3.5 Global Companies Allogeneic Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Allogeneic Stem Cells Players in Global Market
3.6.1 List of Global Tier 1 Allogeneic Stem Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Allogeneic Stem Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Allogeneic Stem Cells Market Size Markets, 2022 & 2029
4.1.2 Progesterone Oral
4.1.3 Progesterone Injection
4.1.4 Progesterone Suspended/Gel
4.2 By Type - Global Allogeneic Stem Cells Revenue & Forecasts
4.2.1 By Type - Global Allogeneic Stem Cells Revenue, 2018-2023
4.2.2 By Type - Global Allogeneic Stem Cells Revenue, 2024-2029
4.2.3 By Type - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Allogeneic Stem Cells Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacies & Drug Stores
5.2 By Application - Global Allogeneic Stem Cells Revenue & Forecasts
5.2.1 By Application - Global Allogeneic Stem Cells Revenue, 2018-2023
5.2.2 By Application - Global Allogeneic Stem Cells Revenue, 2024-2029
5.2.3 By Application - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Allogeneic Stem Cells Market Size, 2022 & 2029
6.2 By Region - Global Allogeneic Stem Cells Revenue & Forecasts
6.2.1 By Region - Global Allogeneic Stem Cells Revenue, 2018-2023
6.2.2 By Region - Global Allogeneic Stem Cells Revenue, 2024-2029
6.2.3 By Region - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Allogeneic Stem Cells Revenue, 2018-2029
6.3.2 US Allogeneic Stem Cells Market Size, 2018-2029
6.3.3 Canada Allogeneic Stem Cells Market Size, 2018-2029
6.3.4 Mexico Allogeneic Stem Cells Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Allogeneic Stem Cells Revenue, 2018-2029
6.4.2 Germany Allogeneic Stem Cells Market Size, 2018-2029
6.4.3 France Allogeneic Stem Cells Market Size, 2018-2029
6.4.4 U.K. Allogeneic Stem Cells Market Size, 2018-2029
6.4.5 Italy Allogeneic Stem Cells Market Size, 2018-2029
6.4.6 Russia Allogeneic Stem Cells Market Size, 2018-2029
6.4.7 Nordic Countries Allogeneic Stem Cells Market Size, 2018-2029
6.4.8 Benelux Allogeneic Stem Cells Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Allogeneic Stem Cells Revenue, 2018-2029
6.5.2 China Allogeneic Stem Cells Market Size, 2018-2029
6.5.3 Japan Allogeneic Stem Cells Market Size, 2018-2029
6.5.4 South Korea Allogeneic Stem Cells Market Size, 2018-2029
6.5.5 Southeast Asia Allogeneic Stem Cells Market Size, 2018-2029
6.5.6 India Allogeneic Stem Cells Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Allogeneic Stem Cells Revenue, 2018-2029
6.6.2 Brazil Allogeneic Stem Cells Market Size, 2018-2029
6.6.3 Argentina Allogeneic Stem Cells Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Allogeneic Stem Cells Revenue, 2018-2029
6.7.2 Turkey Allogeneic Stem Cells Market Size, 2018-2029
6.7.3 Israel Allogeneic Stem Cells Market Size, 2018-2029
6.7.4 Saudi Arabia Allogeneic Stem Cells Market Size, 2018-2029
6.7.5 UAE Allogeneic Stem Cells Market Size, 2018-2029
7 Allogeneic Stem Cells Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Allogeneic Stem Cells Major Product Offerings
7.1.4 Merck Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Teva Generics
7.2.1 Teva Generics Company Summary
7.2.2 Teva Generics Business Overview
7.2.3 Teva Generics Allogeneic Stem Cells Major Product Offerings
7.2.4 Teva Generics Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.2.5 Teva Generics Key News & Latest Developments
7.3 Zhejiang Medicine
7.3.1 Zhejiang Medicine Company Summary
7.3.2 Zhejiang Medicine Business Overview
7.3.3 Zhejiang Medicine Allogeneic Stem Cells Major Product Offerings
7.3.4 Zhejiang Medicine Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.3.5 Zhejiang Medicine Key News & Latest Developments
7.4 Zhejiang Aisheng Pharmaceutical
7.4.1 Zhejiang Aisheng Pharmaceutical Company Summary
7.4.2 Zhejiang Aisheng Pharmaceutical Business Overview
7.4.3 Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Major Product Offerings
7.4.4 Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.4.5 Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
7.5 Besins Healthcare
7.5.1 Besins Healthcare Company Summary
7.5.2 Besins Healthcare Business Overview
7.5.3 Besins Healthcare Allogeneic Stem Cells Major Product Offerings
7.5.4 Besins Healthcare Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.5.5 Besins Healthcare Key News & Latest Developments
7.6 Virtus Pharmaceuticals
7.6.1 Virtus Pharmaceuticals Company Summary
7.6.2 Virtus Pharmaceuticals Business Overview
7.6.3 Virtus Pharmaceuticals Allogeneic Stem Cells Major Product Offerings
7.6.4 Virtus Pharmaceuticals Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.6.5 Virtus Pharmaceuticals Key News & Latest Developments
7.7 BionPharma
7.7.1 BionPharma Company Summary
7.7.2 BionPharma Business Overview
7.7.3 BionPharma Allogeneic Stem Cells Major Product Offerings
7.7.4 BionPharma Allogeneic Stem Cells Revenue in Global Market (2018-2023)
7.7.5 BionPharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Allogeneic Stem Cells Market Opportunities & Trends in Global Market
Table 2. Allogeneic Stem Cells Market Drivers in Global Market
Table 3. Allogeneic Stem Cells Market Restraints in Global Market
Table 4. Key Players of Allogeneic Stem Cells in Global Market
Table 5. Top Allogeneic Stem Cells Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Allogeneic Stem Cells Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Allogeneic Stem Cells Revenue Share by Companies, 2018-2023
Table 8. Global Companies Allogeneic Stem Cells Product Type
Table 9. List of Global Tier 1 Allogeneic Stem Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Allogeneic Stem Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Allogeneic Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Allogeneic Stem Cells Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Allogeneic Stem Cells Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Allogeneic Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Allogeneic Stem Cells Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Allogeneic Stem Cells Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Allogeneic Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Allogeneic Stem Cells Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Allogeneic Stem Cells Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Allogeneic Stem Cells Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Allogeneic Stem Cells Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Allogeneic Stem Cells Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Allogeneic Stem Cells Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Allogeneic Stem Cells Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Allogeneic Stem Cells Product Offerings
Table 32. Merck Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. Teva Generics Company Summary
Table 35. Teva Generics Allogeneic Stem Cells Product Offerings
Table 36. Teva Generics Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Generics Key News & Latest Developments
Table 38. Zhejiang Medicine Company Summary
Table 39. Zhejiang Medicine Allogeneic Stem Cells Product Offerings
Table 40. Zhejiang Medicine Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 41. Zhejiang Medicine Key News & Latest Developments
Table 42. Zhejiang Aisheng Pharmaceutical Company Summary
Table 43. Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Product Offerings
Table 44. Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 45. Zhejiang Aisheng Pharmaceutical Key News & Latest Developments
Table 46. Besins Healthcare Company Summary
Table 47. Besins Healthcare Allogeneic Stem Cells Product Offerings
Table 48. Besins Healthcare Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 49. Besins Healthcare Key News & Latest Developments
Table 50. Virtus Pharmaceuticals Company Summary
Table 51. Virtus Pharmaceuticals Allogeneic Stem Cells Product Offerings
Table 52. Virtus Pharmaceuticals Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 53. Virtus Pharmaceuticals Key News & Latest Developments
Table 54. BionPharma Company Summary
Table 55. BionPharma Allogeneic Stem Cells Product Offerings
Table 56. BionPharma Allogeneic Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 57. BionPharma Key News & Latest Developments
List of Figures
Figure 1. Allogeneic Stem Cells Segment by Type in 2022
Figure 2. Allogeneic Stem Cells Segment by Application in 2022
Figure 3. Global Allogeneic Stem Cells Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Allogeneic Stem Cells Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Allogeneic Stem Cells Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Allogeneic Stem Cells Revenue in 2022
Figure 8. By Type - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 9. By Application - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 10. By Type - Global Allogeneic Stem Cells Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 12. By Application - Global Allogeneic Stem Cells Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 14. By Region - Global Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 15. By Country - North America Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 16. US Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 20. Germany Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 21. France Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 28. China Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 32. India Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 34. Brazil Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Allogeneic Stem Cells Revenue Market Share, 2018-2029
Figure 37. Turkey Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Allogeneic Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Generics Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Zhejiang Medicine Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Besins Healthcare Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Virtus Pharmaceuticals Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BionPharma Allogeneic Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
